LAG3 anticorps (N-Term) (Biotin)
Aperçu rapide pour LAG3 anticorps (N-Term) (Biotin) (ABIN2295951)
Antigène
Voir toutes LAG3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- N-Term
-
Séquence
- GPPAAAPGHP LAPGPHPAAP SSWGPRPRRY
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223) (Biotin)
-
Purification
- Purified by Protein A Sepharose chromatography. .
-
Pureté
- >95 % SDS-PAGE
-
Immunogène
- Synthetic peptide corresponding to 30 aa (GPPAAAPGHPLAPGPHPAAPSSWGPRPRRY) from the first N-terminal D1 domain of human LAG-3 (lymphocyte activation gene-3).
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Autre désignation
- LAG-3
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Antigène
-